Location of Repository

The Contrasting Relationships between Betaine and Homocysteine in Two Clinical Cohorts are Associated with Plasma Lipids and Drug Treatments

By Michael Lever, Peter M. George, Wendy Atkinson, Jane L. Elmslie, Sandy Slow, Sarah L. Molyneux, Richard W. Troughton, A. Mark Richards, Christopher M. Frampton and Stephen T. Chambers
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3292573
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Preview

    Citations

    1. (2009). 1H-nuclear magnetic resonance spectroscopy-based metabolic assessment in a rat model of obesity induced by a high-fat diet.
    2. (1994). Abnormal glycine betaine content of the blood and urine of diabetic and renal patients.
    3. (2006). Aracyl triflates for preparing fluorescent and UV absorbing derivatives of unreactive carboxylates, amines and other metabolites.
    4. (2004). Betaine as a determinant of postmethionine load total plasma homocysteine before and after B-vitamin supplementation.
    5. (2012). Betaine excretion correlates with plasma homocysteine when plasma lipids are elevated,
    6. (2004). Betaine in human nutrition.
    7. (2005). Betaine: a key modulator of onecarbon metabolism and homocysteine status.
    8. (2011). Choline and betaine in health and disease.
    9. (2011). Deletion of betainehomocysteine S-methyltransferase in mice perturbs choline and 1-carbon metabolism, resulting in fatty liver and hepatocellular carcinomas.
    10. (2006). Development of laboratory tests for assessing vitamin status.
    11. (2010). Dietary intake of S-(d-carboxybutyl)-DL-homocysteine induces hyperhomocysteinemia in rats.
    12. (2008). Divergent associations of plasma choline and betaine with components of metabolic syndrome in middle age and elderly men and women.
    13. (2008). Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial.
    14. (1999). Elevated glycine betaine excretion in diabetes mellitus patients is associated with proximal tubular dysfunction and hyperglycemia.
    15. (2009). Fibrates may cause an abnormal urinary betaine loss which is associated with elevations in plasma homocysteine.
    16. (2007). Homocysteine and cardiovascular risk: considering the evidence in the context of study design, folate fortification, and statistical power.
    17. (2006). Homocysteine lowering and cardiovascular events after acute myocardial infarction.
    18. (2005). Homocysteine, glycine betaine, and N,N-dimethylglycine in patients attending a lipid clinic.
    19. (2007). Hyperhomocysteinaemia: a critical review of old and new aspects.
    20. (2007). Interand intra-individual variations in normal urinary glycine betaine excretion.
    21. (2009). Plasma dependent and independent accumulation of betaine in male and female rat tissues.
    22. (2011). Plasma lipids and betaine are related in an Acute Coronary Syndrome Cohort.
    23. (2011). Reconciling the evidence on serum homocysteine and ischaemic heart disease: a meta-analysis. PLoS
    24. (2006). Separation of cationic aracyl derivatives of betaines and related compounds.
    25. (2007). Sex differences in the control of plasma concentrations and urinary excretion of glycine betaine in patients attending a lipid disorders clinic.
    26. (2010). The clinical significance of betaine, an osmolyte with a key role in methyl group metabolism.
    27. (2006). The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators
    28. (2011). The homocysteine controversy.
    29. (2001). The prognostic value of B-type natriuretic peptides in patients with acute coronary syndromes.
    30. (2009). Use of framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.